U.S. Markets open in 7 hrs 5 mins

AIM ImmunoTech Inc. (AIM)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
2.0100-0.0800 (-3.83%)
At close: 4:00PM EDT
Sign in to post a message.
  • M
    Mg
    Where is TIM? He was super active when AIM went up to 2.4$... where is he hiding now ?
  • L
    Luc
    Probably this weekend news around the Shionogi decision ….

    once again rejected or not ?? ( where's the vision boy when you need him ????)

    My prediction : rejected 100% / accepted 0 %

    just mho based on 25 years experience
  • J
    Jeffery
    I had a VISION guys!!!!

    I saw mor ons.... all over the place..
    EVERYWHERE...

    Then, my VISION directed me to this board.
    Hmmmmm.... I wonder 🤔 what my VISION was trying to tell 🤔 me???

    🤣🤣😆
  • L
    Luckyman18
    Once more unto the cusp, dear friends, once more;

    Always, once more...
  • B
    BachelorOfHorse
    trading is so frustrating sometimes. I had found a stock, whose rising was foreseeable. But I hadnt enough money to build a large position. And my other positions did not rise fast enough that I could transfer money to that good stock.
  • J
    Jeffery
    Im gunna laugh when this breaks out of the 5-year resistance, and jumps to $100
  • M
    Mg
    12 message, not counting replies, in 4 days? What has happened to boiler room?
  • K
    Kumar
    AIM is the only one in the line for CFS treatment so $100 is possible buddy
  • B
    BachelorOfHorse
    right around the corner... yawn. There are too many corners. Must be a maze.
  • M
    Mg
    Hi everyone,
    I am back, seeing new name...
  • M
    Mg
    BenK, you had another alias what was it ? I totally forgot...
  • L
    Luc
    Who's gonna bring the Japanese rejection news ?
  • L
    Luc
    pps (pré split from 2019) = 0,047

    not that much for a product that's gonna save the world from covid-19 and cancer !!
  • c
    christine
    Wondering if the short players are starting to feel worried....things are heating up for AIM and with Ampligen being used successfully on at least a hundred ME/CFS patients every year for the last two decades.
    I’m pretty sure FDA approval for Covid19 “long haulers” is coming down the pike.
    What would they have to lose???
    Only potentially benefitting hundreds of thousands of newly ill patients with a post viral chronic illness that is majorly debilitating and has only one medication authorized for treating it. (Currently on a compassionate use basis) and thats...Ampligen!🌟
  • T
    Tom
    Although "Broker Non-Votes" was the biggest vote-getter, Equels & Co get to run AIM for another year.

    Nominees For Withheld Broker Non-Votes
    Thomas K. Equels 3,099,551.9 818,509.6 21,137,232.1
    William M. Mitchell 3,080,232.1 837,829.5 21,137,232.0
    Stewart L. Appelrouth 3,085,778.5 832,283.1 21,137,232.0

    Advisory, non-binding, vote on approval of the compensation of the Company’s Named Executive Officers:

    For: 2,239,872.7 Against: 1,462,457 Abstain: 215,731.9 Broker Non-Vote: 21,137,232

    AIM insiders own only 793,000 shares, so they managed to convince at a few of their investors to vote for them.
  • E
    Ed Struble
    WOW...4 years ago this stock was over $100.00 a share...
  • M
    Markus
    just came back for the comments. 🍻🍿
  • t
    thisismyself
    145 pm eastern time, October 14, 2020. I had a vision of a face changing from a neutral expression to a huge smile, as if they just realized something..
  • T
    Tom
    When a panel of outside experts reviewed the data that HEB/AIM had submitted to the FDA for Ampligen, most agreed that HEB/AIM's veracity could not be trusted.

    From the transcript of that ADCOM meeting:

    "DR. BUCKLEY: Okay. So we're going to be voting on this question, has the safety of Ampligen been adequately assessed and characterized for the treatment of chronic fatigue syndrome?

    ...DR. BUCKLEY: Everyone has voted and the vote is now complete.

    DR. WAPLES: For the record, we have yes, four; no, nine; abstain, zero; and again, no voting, one.

    DR. BUCKLEY: So we'll go around the room again, starting with Dr. Hennessy, stating your name, your vote, reason for your vote, or any comments about future studies.

    DR. HENNESSY: Sure. Sean Hennessy. I voted no. I don't believe that the size or the veracity of the safety database is adequate.

    DR. KOMAROFF: Komaroff. I agree completely. Neither the size nor, more importantly, the veracity of the data presented is persuasive.

    DR. GARDNER: Gardner. I voted no, for the same reason.

    DR. WARE: Ware. I voted no, for those reasons, also.

    DR. D'AGOSTINO: D'Agostino. I voted no for those reasons.

    DR. UNGER: Elizabeth Unger. I voted no, but I was interpreting this question as, has it really been adequately explored? And I do not have confidence in the data with those discrepancies."
  • c
    christine
    AIM received approval from the IRB to enroll “covid19 Long haulers” in receiving Ampligen.
    Ampligen has safely been available for ME/CFS patients who could personally pay $4500/month for the medication for the last 20 years. Several patients testified before Congress that this medication saved their quality of life.
    Safe -check
    Effective -check
    Available to the masses -hopefully coming soon!!!
    Yay!!